Horizon Discovery Limited
Records under this name other than patents Horizon Discovery Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Horizon Discovery Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,450,586 | Somatic haploid human cell line Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,557,151 | Somatic human cell line mutations Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,098,325 | Adeno-Associated Viral Vectors for Gene Therapy Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,227,758 | Somatic haploid human cell line Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,396,664 | Replicative Transposon System Formerly held Lapsed on the fee record Ended Jul 26, 2026 · High confidence | Lapsed on the fee record | Ended Jul 26, 2026 | High confidence |
| US 10,881,648 | Combination Therapy Including an MDM2 Inhibitor and One or More Additional Pharmaceutically Active Agents for the Treatment of Cancers Formerly held Lapsed on the fee record Ended Jan 5, 2025 · Medium confidence | Lapsed on the fee record | Ended Jan 5, 2025 | Medium confidence |